Margitta Worm

Margitta Worm's AcademicInfluence.com Rankings

Margitta Worm

Computer Science

#6032

World Rank

#6361

Historical Rank

Machine Learning

#1821

World Rank

#1845

Historical Rank

Artificial Intelligence

#2071

World Rank

#2106

Historical Rank

Database

#3151

World Rank

#3285

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Margitta Worm Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Margitta Worm's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. (2016) (1154)
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy (2014) (1026)
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology (2014) (814)
2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines (2015) (464)
Direct access to CD4+ T cells specific for defined antigens according to CD154 expression (2005) (457)
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial (2016) (452)
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. (2007) (440)
IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. (1993) (440)
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis (2018) (407)
Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. (2016) (402)
International consensus on (ICON) anaphylaxis (2014) (388)
Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. (2006) (383)
Prevalence of adverse reactions to food in Germany – a population study (2004) (338)
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases (2014) (327)
The epidemiology of anaphylaxis in Europe: a systematic review (2013) (326)
Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. (2000) (315)
Epidemiology of urticaria: a representative cross‐sectional population survey (2010) (289)
World allergy organization anaphylaxis guidance 2020 (2020) (271)
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi‐centre, randomized, dose–response study (2006) (266)
World Allergy Organization Anaphylaxis Guidelines: 2013 Update of the Evidence Base (2013) (256)
Food allergy and non‐allergic food hypersensitivity in children and adolescents (2004) (255)
2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis (2012) (254)
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement (2008) (253)
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans (2019) (250)
1,25‐dihydroxyvitamin D3 promotes IL‐10 production in human B cells (2008) (237)
Cutaneous side‐effects in patients with rheumatic diseases during application of tumour necrosis factor‐α antagonists (2007) (237)
Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta‐analysis (2017) (229)
Regulatory T Cell Specificity Directs Tolerance versus Allergy against Aeroantigens in Humans (2016) (217)
Mast cells as initiators of immunity and host defense (2001) (202)
Variants in a Novel Epidermal Collagen Gene (COL29A1) Are Associated with Atopic Dermatitis (2007) (199)
Eczematous reactions to food in atopic eczema: position paper of the EAACI and GA2LEN (2007) (194)
GA2LEN/EAACI pocket guide for allergen‐specific immunotherapy for allergic rhinitis and asthma (2010) (186)
Guideline for acute therapy and management of anaphylaxis (2014) (184)
Guidelines on the use of extracorporeal photopheresis (2013) (182)
Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis. (2014) (178)
Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy. (2011) (171)
Symptom profile and risk factors of anaphylaxis in Central Europe (2012) (168)
Position paper of the EAACI: food allergy due to immunological cross‐reactions with common inhalant allergens (2015) (168)
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)* (2020) (167)
MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine (2011) (166)
Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland. (2014) (162)
Can we identify patients at risk of life‐threatening allergic reactions to food? (2016) (160)
Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis. (2011) (159)
Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features (2011) (153)
Research needs in allergy: an EAACI position paper, in collaboration with EFA (2012) (151)
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials (2016) (149)
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists (2005) (143)
Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry (2018) (142)
Classical conditioning and expectancy in placebo hypoalgesia: A randomized controlled study in patients with atopic dermatitis and persons with healthy skin (2007) (141)
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes (2017) (141)
Precision medicine in allergic disease—food allergy, drug allergy, and anaphylaxis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology (2017) (141)
Guideline for the diagnosis of drug hypersensitivity reactions (2015) (136)
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach (2021) (135)
Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD). (2016) (128)
Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group (2004) (127)
Insulin allergy: clinical manifestations and management strategies (2008) (127)
Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis (2014) (125)
Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study (2009) (125)
1α,25‐dihydroxyvitamin D3 inhibits anti‐CD40 plus IL‐4‐mediated IgE production in vitro (2002) (123)
COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee (2021) (120)
Management of anaphylaxis: a systematic review (2014) (114)
Guidelines on the management of IgE-mediated food allergies (2015) (113)
Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo (1996) (113)
S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid (2015) (108)
Time to revisit the definition and clinical criteria for anaphylaxis? (2019) (106)
Interleukin-17A promotes IgE production in human B cells. (2010) (104)
Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis (2004) (103)
1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. (2002) (102)
German guidelines for the diagnosis and therapy of localized scleroderma (2016) (100)
Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge. (2009) (97)
Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming. (2015) (97)
S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid (2015) (97)
Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema (2010) (96)
Low‐dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis (2009) (92)
Post‐treatment efficacy of discontinuous treatment with 300IR 5‐grass pollen sublingual tablet in adults with grass pollen‐induced allergic rhinoconjunctivitis (2013) (91)
Food‐induced fatal anaphylaxis: From epidemiological data to general prevention strategies (2018) (91)
Association of the toll‐like receptor 2 A‐16934T promoter polymorphism with severe atopic dermatitis (2009) (88)
Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis (2007) (86)
The role of mobile health technologies in allergy care: An EAACI position paper (2019) (85)
Autocrine IL‐10 promotes human B‐cell differentiation into IgM‐ or IgG‐secreting plasmablasts (2014) (85)
Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double‐blind, controlled trial (2008) (83)
Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score (2015) (82)
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis (2014) (82)
Anaphylaxis treatment: current barriers to adrenaline auto‐injector use (2014) (81)
Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial (2017) (80)
The urgent need for a harmonized severity scoring system for acute allergic reactions (2018) (79)
Anaphylaxis in an emergency setting – elicitors, therapy and incidence of severe allergic reactions (2012) (79)
Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis (2015) (79)
Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule. (2002) (79)
Immunoglobulin E-reactivity of wheat-allergic subjects (baker's asthma, food allergy, wheat-dependent, exercise-induced anaphylaxis) to wheat protein fractions with different solubility and digestibility. (2004) (77)
Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. (2009) (77)
Association of vitamin D receptor gene polymorphisms with severe atopic dermatitis in adults (2013) (77)
EAACI guidelines: Anaphylaxis (2021 update) (2021) (75)
Development of alopecia areata universalis in a patient receiving adalimumab. (2006) (73)
S2k guideline on diagnosis and treatment of atopic dermatitis – short version (2016) (73)
Epinephrine in Severe Allergic Reactions: The European Anaphylaxis Register. (2018) (73)
Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria. (2002) (73)
Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis (2019) (71)
Type‐IV sensitization profile of individuals with atopic eczema: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG) (2006) (71)
Patch testing in children – recommendations of the German Contact Dermatitis Research Group (DKG) (2007) (70)
Provoking allergens and treatment of anaphylaxis in children and adolescents – data from the anaphylaxis registry of German‐speaking countries (2011) (69)
Implementation of Anaphylaxis Management Guidelines: A Register-Based Study (2012) (68)
Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32 (2018) (68)
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity (1994) (67)
Polyethylene glycol as a cause of anaphylaxis (2016) (67)
1,25-dihydroxyvitamin D3 impairs NF-κB activation in human naïve B cells. (2011) (67)
Allergic contact dermatitis in children: which factors are relevant? (review of the literature) (2013) (66)
Systemic PPARgamma ligation inhibits allergic immune response in the skin. (2008) (64)
S2k guideline on diagnosis and treatment of atopic dermatitis — short version (2016) (64)
Frequency of atopic dermatitis and relevance of food allergy in adults in Germany. (2006) (63)
CD40 ligation induces lymphotoxin alpha gene expression in human B cells. (1994) (63)
EAACI position paper for practical patch testing in allergic contact dermatitis in children (2015) (61)
Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews (2017) (60)
German guideline for the management of adverse reactions to ingested histamine (2017) (60)
S3 guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 1 (2019) (60)
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article. (2011) (59)
Impact of native, heat‐processed and encapsulated hazelnuts on the allergic response in hazelnut‐allergic patients (2009) (59)
The placebo effect in allergen-specific immunotherapy trials (2013) (58)
Mycophenolate mofetil is effective for maintenance therapy of hypocomplementaemic urticarial vasculitis (2000) (58)
Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study. (2016) (58)
Critical view of anaphylaxis epidemiology: open questions and new perspectives (2018) (57)
Retinoic acid inhibits CD40 + interleukin-4-mediated IgE production in vitro. (1998) (57)
Malassezia spp.-specific immunoglobulin E level is a marker for severity of atopic dermatitis in adults. (2015) (57)
A nematode immunomodulator suppresses grass pollen-specific allergic responses by controlling excessive Th2 inflammation. (2013) (55)
Evaluation of commercial skin prick test solutions for selected occupational allergens (2013) (55)
Guideline on the Management of Hand Eczema ICD‐10 Code: L20. L23. L24. L25. L30 (2009) (55)
Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double‐blind, vehicle‐controlled phase IIa study (2020) (53)
The German Multicentre Study on Multiple Chemical Sensitivity (MCS). (2008) (53)
ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – An EAACI‐ARIA Position Paper (2020) (53)
Antihistamine‐resistant urticaria factitia successfully treated with anti‐immunoglobulin E therapy (2010) (52)
Causes and risk factors for anaphylaxis (2013) (52)
Agreement of efficacy assessments for five‐grass pollen sublingual tablet immunotherapy (2009) (51)
Oral vitamin D increases the frequencies of CD38+ human B cells and ameliorates IL‐17‐producing T cells (2014) (50)
Vitamin D receptor binds to the ε germline gene promoter and exhibits transrepressive activity. (2010) (49)
Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update (2021) (49)
[AWMF Guideline no. 013/066. Diagnosis and therapy of circumscribed scleroderma]. (2009) (48)
Introducing Genetic Testing for Adult-Type Hypolactasia (2005) (48)
Guidelines on dermatomyositis – excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology (2016) (48)
Neurodermitis S2‐Leitlinie (2009) (48)
Food allergies resulting from immunological cross-reactivity with inhalant allergens (2014) (47)
Retinoid‐ and carotenoid‐enriched diets influence the ontogenesis of the immune system in mice (2003) (46)
Evidence for novel tomato seed allergens: IgE-reactive legumin and vicilin proteins identified by multidimensional protein fractionation-mass spectrometry and in silico epitope modeling. (2009) (46)
Propionibacterium acnes Abundance Correlates Inversely with Staphylococcus aureus: Data from Atopic Dermatitis Skin Microbiome. (2018) (46)
S3-Guideline on allergy prevention: 2014 update (2014) (46)
Towards a European registry of severe allergic reactions: current status of national registries and future needs (2010) (45)
Elicitors and co-factors in food-induced anaphylaxis in adults (2013) (44)
Vitamin D receptor activation improves allergen-triggered eczema in mice. (2012) (43)
Oral administration of Escherichia coli Nissle 1917 prevents allergen‐induced dermatitis in mice (2011) (43)
Quantitative patch and repeated open application testing in methyldibromo glutaronitrile‐sensitive patients (2005) (43)
Quantitative patch and repeated open application testing in hydroxyisohexyl 3‐cyclohexene carboxaldehyde sensitive‐patients (2009) (43)
Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients (2016) (43)
Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors. (2002) (42)
Changing the history of anaphylaxis mortality statistics through the World Health Organization's International Classification of Diseases-11. (2019) (42)
Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study (2014) (42)
Decreased retinoid concentration and retinoid signalling pathways in human atopic dermatitis (2011) (42)
Impaired T cell activation and cytokine production by calcitriol‐primed human B cells (2014) (41)
Ethanol as a cause of hypersensitivity reactions to alcoholic beverages (2002) (41)
European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis (2017) (41)
Increased leukotriene production by food additives in patients with atopic dermatitis and proven food intolerance (2001) (40)
Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicentre diagnostic accuracy study (2010) (39)
25-Hydroxvitamin D3 Promotes the Long-Term Effect of Specific Immunotherapy in a Murine Allergy Model (2014) (39)
Diagnosis and Therapy of Localized Scleroderma (2009) (39)
Contact sensitization in patients with suspected cosmetic intolerance: results of the IVDK 2006–2011 (2015) (38)
BASALIT trial: double‐blind placebo‐controlled allergen immunotherapy with rBet v 1‐FV in birch‐related soya allergy (2017) (38)
CD40 ligation and IL‐4 use different mechanisms of transcriptional activation of the human lymphotoxin α promoter in B cells (1998) (38)
Anaphylaxis in Elderly Patients—Data From the European Anaphylaxis Registry (2019) (38)
Guideline on diagnostic procedures for suspected hypersensitivity to beta-lactam antibiotics (2019) (37)
Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA (2021) (37)
Risk factors of adverse reactions to food in German adults (2009) (37)
Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment (2009) (37)
A 300°IR sublingual tablet is an effective, safe treatment for house-dust-mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized Phase III clinical trial. (2020) (37)
Dupilumab in the treatment of moderate-to-severe atopic dermatitis (2017) (35)
Role of Adverse Reactions to Food in Urticaria and Exercise-Induced Anaphylaxis (2002) (35)
Inhibition of IgE-production by peroxisome proliferator-activated receptor ligands. (2003) (35)
Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis. (2006) (35)
Liver X Receptors Control IgE Expression in B Cells1 (2009) (34)
Allergy for a lifetime? (2010) (34)
Meat allergy associated with galactosyl‐α‐(1,3)‐galactose (α‐Gal)—Closing diagnostic gaps by anti‐α‐Gal IgE immune profiling (2018) (34)
S3 Guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 2 (2019) (34)
Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany (2019) (34)
Schnitzler's syndrome: successful treatment of two patients using thalidomide (2003) (33)
Allergenic activity of different tomato cultivars in tomato allergic subjects (2011) (33)
Efficient tetanus toxoid immunization on vitamin D supplementation (2011) (33)
Subclinical activation of latent cytomegalovirus (CMV) infection and anti‐CMV immune response in patients with atopic dermatitis (2003) (33)
S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update (2020) (33)
Diagnosing, managing and preventing anaphylaxis: Systematic review (2020) (33)
Measurement of Proliferative Responses of Cultured Lymphocytes (1994) (33)
Inhibition of IgE production by docosahexaenoic acid is mediated by direct interference with STAT6 and NFκB pathway in human B cells. (2011) (33)
Penetration of Pollen Proteins into the Skin (2007) (33)
Effects of Retinoids on in vitro and in vivo IgE Production (2001) (31)
A combination of wheatflour, ethanol and food additives inducing FDEIA (2002) (31)
Phenotype and risk factors of venom-induced anaphylaxis: a case-control study of the European Anaphylaxis Registry. (2020) (31)
Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany (2020) (31)
Molecular regulation of human IgE synthesis (1997) (30)
Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model (2020) (29)
Differential immunomodulating effects of inactivated probiotic bacteria on the allergic immune response. (2007) (29)
Type I sensitization towards patent blue as a cause of anaphylaxis (2003) (28)
Novel Unconventional Therapeutic Approaches to Atopic Eczema (2000) (28)
Cat peptide antigen desensitisation for treating cat allergic rhinoconjunctivitis (2013) (28)
Immunomodulation in Patients with Chronic Hand Eczema Treated with Oral Alitretinoin (2014) (28)
Role of vitamin A elimination or supplementation diets during postnatal development on the allergic sensitisation in mice. (2007) (28)
Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alterations of sCD23, sCD54 and IL-6 production (2005) (28)
A cold-response index for the assessment of Raynaud's phenomenon. (2007) (28)
Exogenous histamine aggravates eczema in a subgroup of patients with atopic dermatitis. (2009) (28)
Serum levels of 9α,11β-PGF2 and cysteinyl leukotrienes are useful biomarkers of anaphylaxis. (2016) (28)
Recurrent eczema herpeticum – a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients (2019) (28)
Refractory Anaphylaxis: Data From the European Anaphylaxis Registry (2019) (27)
Rituximab preserves vision in ocular mucous membrane pemphigoid (2015) (27)
Transcriptomic and lipidomic profiling of eicosanoid/docosanoid signalling in affected and non‐affected skin of human atopic dermatitis patients (2019) (27)
COVID‐19 and implications for dermatological and allergological diseases (2020) (27)
Allergen and allergy risk assessment, allergen management, and gaps in the European Food Information Regulation (FIR) (2015) (27)
S2k‐Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion (2016) (27)
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic (2020) (27)
Infrared‐monitored cold response in the assessment of Raynaud's phenomenon (2006) (27)
Severe allergic reactions to the COVID-19 vaccine – statement and practical consequences (2021) (26)
Amelanotic malignant melanoma presenting as malignant schwannoma (1993) (26)
Allergen extract‐induced interleukin‐10 in human memory B cells inhibits immunoglobulin E production (2009) (25)
Safety of a rush immunotherapy build-up schedule with depigmented polymerized allergen extracts. (2010) (25)
Thymic stromal lymphopoietin induction by skin irritation is independent of tumour necrosis factor‐α, but supported by interleukin‐1 (2015) (25)
Risk factors and characteristics of biphasic anaphylaxis. (2020) (25)
CD40-CD40 ligand (CD40L) interactions and X-linked hyperIgM syndrome (HIGMX-1). (1995) (25)
Adrenaline in the Acute Treatment of Anaphylaxis. (2018) (24)
Predominance of the major allergen (Alt a I) in Alternaria sensitized patients (1993) (24)
Low-dose, but not high-dose, cyclosporin A promotes regulatory T-cell induction, expansion, or both. (2010) (24)
S3-Leitlinie Allergieprävention — Update 2014 (2014) (24)
Effects of various synthetic retinoids on proliferation and immunophenotype of human melanoma cells in vitro. (1995) (24)
Recommendation: Dermatologist's procedure (2007) (24)
Allergological approach to drug hypersensitivity reactions (2008) (24)
Tamoxifen counteracts the allergic immune response and improves allergen‐induced dermatitis in mice (2010) (23)
Impact of arbuscular mycorrhizal fungi on the allergenic potential of tomato (2011) (23)
Whole blood flow cytometric measurement of NFATc1 and IL‐2 expression to analyze cyclosporine A‐mediated effects in T cells (2010) (23)
CD40‐mediated lymphotoxin α expression in human B cells is tyrosine kinase dependent (1995) (23)
Clopidogrel-associated angioedema. (2003) (23)
Lymphotoxin‐α is an important autocrine factor for CD40+interleukin‐4‐mediated B‐cell activation in normal and atopic donors (1998) (23)
New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs) (2016) (22)
Non-celiac gluten/wheat sensitivity (NCGS)—a currently undefined disorder without validated diagnostic criteria and of unknown prevalence (2018) (22)
Long‐term reduction in local inflammation by a lipid raft molecule in atopic dermatitis (2010) (22)
Modulation of cytokine production by low and high retinoid diets in ovalbumin-sensitized mice. (2004) (22)
[Atopic dermatitis: S2 guidelines]. (2009) (21)
Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells. (1994) (21)
Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy (2018) (21)
Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo‐controlled, randomized, phase III clinical trial (ECZTRA 7) * (2021) (21)
Impact of sex on anaphylaxis severity--data from the Anaphylaxis Registry. (2015) (21)
Late reactions to patch test preparations with reduced concentrations of p‐phenylenediamine: a multicentre investigation of the German Contact Dermatitis Research Group (2011) (21)
Epidemiology of anaphylaxis. (2010) (21)
Sugar is not an aggravating factor in atopic dermatitis. (2001) (21)
Retinoic acid potentiates inflammatory cytokines in human mast cells: Identification of mast cells as prominent constituents of the skin retinoid network (2015) (21)
Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA (2020) (21)
Update of the S2k guideline on the management of IgE-mediated food allergies (2021) (20)
Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season. (2018) (20)
An efficient method for gene knock‐down by RNA interference in human skin mast cells (2017) (20)
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies (2016) (20)
Dietary polyunsaturated fatty acids and non‐digestible oligosaccharides reduce dermatitis in mice (2013) (20)
Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials (2019) (20)
Care of anaphylaxis among practising doctors (2008) (20)
Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts (2021) (19)
Human Langerhans Cells Control Th Cells via Programmed Death-Ligand 1 in Response to Bacterial Stimuli and Nickel-Induced Contact Allergy (2012) (19)
PGE2 deficiency predisposes to anaphylaxis by causing mast cell hyper-responsiveness. (2020) (19)
Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany (2021) (19)
Wheat anaphylaxis in adults differs from reactions to other types of food. (2021) (19)
Practical handling of allergic reactions to COVID-19 vaccines (2021) (19)
Modern therapies in atopic dermatitis: biologics and small molecule drugs (2020) (18)
Update “Systemic treatment of atopic dermatitis” of the S2k‐guideline on atopic dermatitis (2021) (18)
A Promoter Polymorphism of the Vitamin D Metabolism Gene Cyp24a1 is Associated with Severe Atopic Dermatitis in Adults. (2016) (18)
Dietary docosahexaenoic acid in combination with arachidonic acid ameliorates allergen‐induced dermatitis in mice (2011) (18)
Prevalence and treatment profile of patients with grass pollen and house dust mite allergy (2013) (18)
Contact urticaria: Frequency, elicitors and cofactors in three cohorts (Information Network of Departments of Dermatology; Network of Anaphylaxis; and Department of Dermatology, University Hospital Erlangen, Germany) (2019) (18)
Thymic Stromal Lymphopoietin Interferes with the Apoptosis of Human Skin Mast Cells by a Dual Strategy Involving STAT5/Mcl-1 and JNK/Bcl-xL (2019) (18)
Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema (2016) (18)
Perioral contact dermatitis caused by L‐carvone in toothpaste (1998) (18)
In-flight allergic emergencies (2017) (17)
Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol (2017) (17)
Olive Oil-Derived Polyphenols Effectively Attenuate Inflammatory Responses of Human Keratinocytes by Interfering with the NF-κB Pathway. (2019) (17)
The epidemiology of anaphylaxis in Europe: protocol for a systematic review (2013) (17)
Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions. (1999) (17)
Pepino mosaic virus Infection of Tomato Affects Allergen Expression, but Not the Allergenic Potential of Fruits (2013) (17)
Dose‐response relationship of a new Timothy grass pollen allergoid in comparison with a 6‐grass pollen allergoid (2017) (17)
Specific Immunotherapy (hyposensitization) for IgE-mediated allergic diseases* (2010) (17)
Allergen‐mediated modulation of CD23 expression is interferon‐γ and interleukin‐10 dependent in allergic and non‐allergic individuals (2003) (17)
Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication (2019) (17)
Risk factors and treatment of refractory anaphylaxis - a review of case reports (2018) (17)
Thymic stromal lymphopoietin production induced by skin irritation results from concomitant activation of protease‐activated receptor 2 and interleukin 1 pathways (2019) (16)
Topical therapy of hand eczema – analysis of the prescription profile from dermatologists in private practice (2012) (16)
Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab (2019) (16)
Benzoyl peroxide as a cause of airborne contact dermatitis in an orthopaedic technician (2002) (16)
New trends in anaphylaxis (2017) (16)
Characterization of oral immune cells in birch pollen‐allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen‐presenting cells (2015) (16)
Neutrophil respiratory burst is decreased in scleroderma and normalized by near‐infrared mediated hyperthermia (2006) (16)
[Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany]. (2018) (16)
The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle‐controlled study (2010) (16)
Development of subcutaneous allergen immunotherapy (part 2): preventive aspects and innovations (2019) (15)
Tolerability and Clinical Outcome of Coseasonal Treatment with Escherichia coli Strain Nissle 1917 in Grass Pollen-Allergic Subjects (2013) (15)
COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) – A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA) (2021) (15)
Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review (2016) (15)
9‐cis retinoic acid modulates the type I allergic immune response (2017) (15)
Standardization of double blind placebo controlled food challenge with soy within a multicentre trial (2016) (15)
Novel therapies for atopic eczema. (2002) (15)
Analysis of in vivo penetration of textile dyes causing allergic reactions (2009) (15)
Fatty acid composition of serum lipid classes in mice following allergic sensitisation with or without dietary docosahexaenoic acid-enriched fish oil substitution (2008) (15)
Apoptotic resistance of human skin mast cells is mediated by Mcl-1 (2017) (15)
The acute and long-term management of anaphylaxis: protocol for a systematic review (2013) (15)
Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis. (2021) (15)
Risk factors for severe reactions in food allergy: Rapid evidence review with meta‐analysis (2022) (14)
Detection of Doxorubicin in the Horny Layer in a Patient Suffering from Palmar-Plantar Erythrodysaesthesia (2005) (14)
Exploratory analysis of CD63 and CD203c expression in basophils from hazelnut sensitized and allergic individuals (2016) (14)
Tomato allergy: impact of genotype and environmental factors on the biological response. (2011) (14)
The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase‐1 antibodies (2016) (14)
The allergic emergency – management of severe allergic reactions (2014) (14)
Managing food allergy: GA2LEN guideline 2022 (2022) (14)
[In vitro allergy diagnosis. Guideline of the German Society of Asthma and Immunology in conjunction with the German Society of Dermatology]. (2006) (13)
Multicentric reticulohistiocytosis indicating metastasis of an unknown primary tumour. (1998) (13)
The p.Arg435His Variation of IgG3 With High Affinity to FcRn Is Associated With Susceptibility for Pemphigus Vulgaris—Analysis of Four Different Ethnic Cohorts (2018) (13)
Evolution of subcutaneous allergen immunotherapy (part 1): from first developments to mechanism-driven therapy concepts (2019) (13)
Colophony‐induced contact dermatitis due to ECG electrodes in an infant (2007) (13)
Serum levels of 9α,11β‐PGF2 and apolipoprotein A1 achieve high predictive power as biomarkers of anaphylaxis (2017) (13)
The frequency of specific contact allergies is reduced in patients with psoriasis (2018) (13)
Quantitative repeated open application testing with a rinse‐off product in methyldibromo glutaronitrile‐sensitive patients: results of the IVDK (2010) (13)
Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus (2006) (13)
Genomewide association study identifies GALC as susceptibility gene for mucous membrane pemphigoid (2017) (13)
Upregulation of CD40 and CD40 ligand expression in IgE-associated cutaneous diseases. (1997) (13)
Retinoic Acid receptor-gamma-selective retinoids exert antiproliferative effects on human-melanoma cell-growth in-vitro. (1994) (13)
TCRs with segment TRAV9‐2 or a CDR3 histidine are overrepresented among nickel‐specific CD4+ T cells (2020) (13)
Identification of putative new tomato allergens and differential interaction with IgEs of tomato allergic subjects (2013) (13)
Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry (2019) (12)
Food-induced anaphylaxis and cofactors – data from the anaphylaxis registry (2017) (12)
Guideline on management of suspected adverse reactions to ingested histamine (2021) (12)
Tralokinumab in atopic dermatitis (2021) (12)
Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study (2015) (12)
Infrared-mediated hyperthermia is effective in the treatment of scleroderma-associated Raynaud's phenomenon. (2005) (12)
10 years quality assurance of the dermatologist's procedure. ABD review board part II: 2003–2009 (2011) (12)
ICER report for peanut OIT comes up short. (2019) (12)
How to Psychologically Minimize Scratching Impulses Benefits of Placebo Effects on Itching Using Classical Conditioning and Expectancy (2014) (12)
Wasp Venom Rush Immunotherapy Induces Transient Downregulation of B Cell Surface Molecule Expression (2002) (12)
Management of anaphylaxis due to COVID‐19 vaccines in the elderly (2021) (11)
Rituximab in patients with recalcitrant autoimmune blistering diseases: experience in a cohort of 22 patients (2015) (11)
[The registry for severe allergic reactions in German-speaking countries. Recent data and perspectives]. (2012) (11)
Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here? (2020) (11)
Epinephrine delivery via EpiPen® Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances (2020) (11)
In vitro sensitivity of human melanoma cells to chemotherapeutic agents and interferons (1994) (11)
S3 Guideline Allergy Prevention* (2022) (11)
Opposing effects on immune function and skin barrier regulation by the proteasome inhibitor bortezomib in an allergen‐induced eczema model (2013) (11)
Olaparib Desensitization in a Patient with Recurrent Peritoneal Cancer. (2018) (11)
Responsiveness to interferon treatment of human melanoma cells correlates to immunophenotype. (1993) (11)
[Covid-19 vaccination and risk of anaphylaxis - Recommendations for practical management]. (2021) (10)
Randomized immunotherapy trial in dual‐allergic patients using “active allergen placebo” as control (2019) (10)
Immunophenotypic characterization of peripheral B cells. During short-term immunotherapy with tree pollen allergoid and the immunoadjuvant monophosphoryl lipid A. (2002) (10)
A variant of the CXCL11 gene may influence susceptibility to contact allergy, particularly in polysensitized patients (2016) (10)
Identification of IgE Binding to Api g 1‐Derived Peptides (2010) (10)
Targeted Use of Placebo Effects Decreases Experimental Itch in Atopic Dermatitis Patients: A Randomized Controlled Trial (2021) (10)
Contact dermatitis and sensitization in professional musicians (2019) (10)
Occupational airborne contact allergy to tetrazepam in a geriatric nurse (2009) (10)
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitisA phase 2b randomized study. (2020) (10)
Cost utility analysis of the SQ® HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting (2016) (10)
Expression of growth factor receptors on human melanoma cells: Comparison of modulating effects of interferons and retinoids (1993) (10)
Persistent cow′s milk anaphylaxis from early childhood monitored by IgE and BAT to cow′s and human milk under therapy (2018) (10)
Activation of Tumor Necrosis Factor-α and Lymphotoxin-α via Anti-CD40 in Human B Cells (1995) (10)
A 7‐step consultation plan for health care workers and hairdressers (2007) (10)
Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2‐year double‐blind, placebo‐controlled, randomized trial plus 1‐year open‐label extension (2019) (10)
Prospective safety analysis of an ultrarush specific immunotherapy in adults with wasp venom allergy (2006) (9)
Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosis. (2016) (9)
Clinical Efficacy and Tolerability of a Novel Selective Corticosteroid in Atopic Dermatitis - Two Randomised Controlled Trials (2015) (9)
Expression and functional role of co-stimulatory molecules in CD40+IL-4-stimulated B cells from atopic and non-atopic donors. (2000) (9)
Intravenous Immunoglobulins in a Series of 32 Rare and Recalcitrant Immune Dermatoses (2020) (9)
Cabbage allergy: a rare cause of food-induced anaphylaxis. (2013) (9)
A case‐control analysis of skin contact allergy in children and adolescents (2019) (9)
Trial of Intravenous Immune Globulin in Dermatomyositis. (2022) (9)
Detection of KIT D816V mutation in patients with severe anaphylaxis and normal basal tryptase - First data from the Anaphylaxis Registry (NORA). (2019) (9)
S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 1: Classification, diagnosis, prevention, activity scores (2021) (9)
Atopy patch testing with aeroallergens in a large clinical population of dermatitis patients in Germany and Switzerland, 2000‐2015: a retrospective multicentre study (2020) (9)
Isolation of Human B Cell Populations (2011) (8)
Interferon‐γ downregulates epidermal growth factor receptors on human melanoma cells (1995) (8)
Endogenous Calcitriol Synthesis Controls the Humoral IgE Response in Mice (2017) (8)
Guideline on allergen immunotherapy in IgE-mediated allergic diseases (2022) (8)
‘Well days’ after sublingual immunotherapy with a high‐dose 6‐grass pollen preparation (2009) (8)
[Food-associated anaphylaxis. Data from the anaphylaxis registry]. (2012) (8)
Gelatin-induced urticaria and anaphylaxis after tick-borne encephalitis vaccine. (2000) (8)
Dupilumab Improves Patient-Reported Outcomes (PROs) in a Phase 2 Study in Adults with Moderate-to-Severe Atopic Dermatitis (2015) (8)
Non-celiac gluten/wheat sensitivity (NCGS)—a currently undefined disorderwithout validated diagnostic criteria and of unknown prevalence Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunology (DGAKI) (2018) (8)
EAACI anaphylaxis guidelines: systematic review protocol (2020) (8)
[Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)]. (2020) (8)
EAACI anaphylaxis guidelines: systematic review protocol (2020) (8)
Quality indicators for the acute and long-term management of anaphylaxis: a systematic review (2017) (8)
Mast cells instruct keratinocytes to produce TSLP - relevance of the tryptase/PAR-2 axis. (2022) (8)
The Impact on Allergy-Related Cells of a Birch Pollen Allergoid, with and without Monophosphoryl Lipid A, in Comparison with the Native Equivalent (2017) (8)
Immunomodulation of high‐dose vitamin D supplementation during allergen‐specific immunotherapy (2020) (8)
Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies (2021) (8)
Proximity-Based Emergency Response Communities for Patients With Allergies Who Are at Risk of Anaphylaxis: Clustering Analysis and Scenario-Based Survey Study (2019) (7)
Anaphylaxis knowledge gaps and future research priorities: a consensus report. (2021) (7)
EAACI Task force Clinical epidemiology of anaphylaxis: experts’ perspective on the use of adrenaline autoinjectors in Europe (2020) (7)
Development and validation of the food allergy severity score (2021) (7)
Sustained clinical efficacy of sublingual immunotherapy with a high-dose grass pollen extract. (2011) (7)
Tolerance induction through early feeding to prevent food allergy in infants with eczema (TEFFA): rationale, study design, and methods of a randomized controlled trial (2022) (7)
Atopic dermatitis and allergic rhinitis – do co‐effects in therapy exist? (2012) (7)
Healthcare provision for insect venom allergy patients during the COVID-19 pandemic (2020) (7)
Food‐induced anaphylaxis morbidity: Emergency department and hospitalization data support preventive strategies (2021) (7)
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper (2021) (7)
[Exercise-induced anaphylaxis]. (2013) (7)
Bortezomib treatment diminishes hazelnut‐induced intestinal anaphylaxis in mice (2016) (7)
Topical and Systemic Corticosteroids (2019) (7)
Supportive care of patients with anaphylaxis — options and shortcomings: an assessment on behalf of the working group on anaphylaxis training and education (AGATE), Germany (2016) (7)
Conflicting verdicts on peanut OIT from the ICER and FDA Advisory Committee; where do we go from here? (2019) (6)
Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in Germans (2021) (6)
Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double‐blind Phase Ib study (2020) (6)
S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics (2021) (6)
Treatment of atopic dermatitis with pimecrolimus – impact on quality of life (2007) (6)
Identification and Purification of Novel Low-Molecular-Weight Lupine Allergens as Components for Personalized Diagnostics (2021) (6)
[Successful treatment of Stewart-Treves syndrome with liposomal doxorubicin]. (2004) (6)
In vitro diagnostics and molecular basis of IgE-mediated food allergies. (2009) (6)
Serological profiling reveals hsa-miR-451a as a possible biomarker of anaphylaxis (2022) (6)
Low-dose Anti-thymocyte Globulin Inhibits Human B-cell Differentiation into Antibody-Secreting Cells. (2015) (6)
Clinical reactivity of celery cultivars in allergic patients: Role of Api g 1 (2018) (6)
SPIREs: a new horizon for allergic disease treatment? (2015) (6)
Component-resolved diagnosis in adult patients with food-dependent anaphylaxis☆ (2021) (6)
[Food-induced anaphylaxis - data from the anaphylaxis registry]. (2016) (5)
Is the concept of “peanut-free schools” useful in the routine management of peanut-allergic children at risk of anaphylaxis? (2020) (5)
Impact of comorbidities on the treatment of atopic dermatitis in clinical practice. (2014) (5)
Triggers and Treatment of Anaphylaxis (2018) (5)
Older age onset of systemic sclerosis – accelerated disease progression in all disease subsets (2020) (5)
Repeated epinephrine doses: An analysis of the European Anaphylaxis Registry, 2007-2018. (2019) (5)
Anaphylaxis to vaccination and polyethylene glycol: a perspective from the European Anaphylaxis Registry (2021) (5)
[Patch testing with the DKG standard series 2001-2004. Results from the IVDK]. (2005) (5)
9‐cis Retinoic acid and 1.25‐dihydroxyvitamin D3 drive differentiation into IgA+ secreting plasmablasts in human naïve B cells (2020) (5)
Allergic contact dermatitis beyond IL‐1β role of additional family members (2014) (5)
Genetic variability of immune‐related lncRNAs: polymorphisms in LINC‐PINT and LY86‐AS1 are associated with pemphigus foliaceus susceptibility (2021) (5)
Genetic association and differential expression of HLAComplexGroup lncRNAs in pemphigus. (2021) (5)
COVID-19 vaccination and allergen immunotherapy (AIT) – A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI) (2021) (4)
Allergies and the skin, an interdisciplinary approach in GA2LEN and EAACI activities (2006) (4)
Safety of dupilumab in patients with atopic dermatitis: expert opinion (2021) (4)
Rhinitis, sinusitis, and ocular diseases Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis (2007) (4)
Data from the anaphylaxis registry of the German-speaking countries (2015) (4)
Efficacy and Safety of Tralokinumab Monotherapy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from Two 52-Week, Phase 3 Trials (ECZTRA 1 and ECZTRA 2) (2020) (4)
Drug-induced anaphylaxis—elicitors, mechanisms and diagnosis (2019) (4)
Keine Empfehlung für IgG- und IgG 4 - Bestimmungen gegen Nahrungsmittel Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen (ÄDA), der Gesellschaft für Pädiatrische Allergologie und Umwelt- medizin (GPA), der Österreichis (2009) (4)
Patch test results with caine mix III and its three constituents in consecutive patients of the IVDK (2021) (4)
Modulation of lymphocyte phenotype and function by immunoglobulins (2006) (4)
Safety and Efficacy Of Dupilumab Versus Placebo For Moderate-To-Severe Atopic Dermatitis In Patients Using Topical Corticosteroids (TCS): Greater Efficacy Observed With Concomitant Therapy Compared To TCS Alone (2014) (4)
Frequency of food allergy in Europe: An updated systematic review and meta‐analysis (2022) (4)
Advances in the management of UVR‐associated skin cancers: autoimmune diseases and UV protection (2009) (4)
Vitamin A controls the allergic response through T follicular helper cell as well as plasmablast differentiation (2020) (4)
Therapy Changes During Pemphigus Management: A Retrospective Analysis (2020) (4)
[Allergic skin reactions. Current survey]. (2008) (4)
TSLP production induced by skin irritation results from the concomitant activation of PAR-2 and IL-1 pathways. (2019) (4)
Usefulness of an artificial neural network to assess anaphylaxis severity (2020) (3)
Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans (2019) (3)
Abstracts from the Food Allergy and Anaphylaxis Meeting 2016 (2017) (3)
Correction to: Guideline for the diagnosis of drug hypersensitivity reactions (2018) (3)
Molekulare Mechanismen der IgE-Regulation (1997) (3)
Brain metastases of metastatic malignant melanoma: Response to DTIC and interferon-gamma (1993) (3)
Elicitors and phenotypes of adult patients with proven IgE‐mediated food allergy and non‐immune‐mediated food hypersensitivity to food additives (2022) (3)
Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic Sclerosis (2020) (3)
Pemphigus Foliaceus—Repeated Treatment With Rituximab 7 Years After Initial Response: A Case Report (2018) (3)
Dietary implications in acetylsalicylic acid intolerance (2020) (3)
Sustained Efficacy of Allert Allergy Vaccine after a Second Birch Pollen Season: A Phase IIb (2015) (3)
Sensitivity of human melanoma cells in vitro to chemotherapy, interferons and combinations of both (1993) (3)
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines -- an EAACI-ARIA Position Paper (2020) (3)
Immunomodulation by vitamin D (2018) (2)
Omalizumab in IgE-mediated food allergy: A systematic review and meta-analysis. (2022) (2)
Q&A: Food additive intolerance (2011) (2)
[Not Available]. (2015) (2)
Editorial: Anaphylaxis – A Distinct Immunological Syndrome, but How Much Do We Really Understand? (2019) (2)
Thymic Stromal Lymphopoietin Interferes with the Apoptosis of Human Skin Mast Cells by a Dual Strategy Involving STAT 5 / Mcl-1 and JNK / Bcl-x L (2019) (2)
Efficacy and Safety of House Dust Mites Allergen Extracts Tablets in Adults With Allergic Rhinitis Patients (2010) (2)
Level of knowledge among pharmacists regarding anaphylaxis and the use of epinephrine autoinjectors (2018) (2)
Anaphylaxis in middle-aged patients (2021) (2)
Genetic background of lactose intolerance and implications for diagnosis (2003) (2)
Persistent contact dermatitis following use of laurel oil (2022) (2)
Allergen immunotherapy in the current COVID-19 pandemic - A position paper of the AeDA, ARIA, EAACI, DGAKI and GPA (2020) (2)
Erratum to: Guidelines on the management of IgE-mediated food allergies (2015) (2)
Ultra-Fast Hypoallergenic Birch Pollen Allergy Vaccine Allert Is Efficient and Safe: Results Of a Phase IIb Study (2014) (2)
COVID-19 in tralokinumab-treated patients with moderate-to- severe atopic dermatitis: case series from the ECZTEND long- term extension trial (2021) (2)
Determination of granulocyte/macrophage-colony-stimulating factor secretion by human melanoma cells and its effects on human melanoma cell proliferation (2005) (2)
Post-treatment, Long-term Efficacy Of A 300IR Sublingual Tablet Of 5-grass Pollen Allergen Extract In Adults With Grass Pollen-induced Allergic Rhinoconjunctivitis: The Relationship With Disease Severity (2012) (2)
Baseline disease signs and symptoms and systemic treatment of patients with atopic dermatitis included in the German AD registry treatgermany (2018) (2)
Sustained Efficacy and Safety Of a Pre-coseasonal 300IR 5-grass Pollen SLIT Tablet Over 3 Pollen Seasons In Adult SAR (2011) (2)
CD40-mediated lymphotoxin alpha expression in human B cells is tyrosine kinase dependent. (1995) (2)
Activation of tumor necrosis factor-alpha and lymphotoxin-alpha via anti-CD40 in human B cells. (1995) (2)
Messages for patients and relatives from the 2021 update of the guideline on acute therapy and management of anaphylaxis (2021) (2)
Ethylene oxide as an occupational contact allergen – an underestimated problem? (2017) (2)
[Topical immunomodulators for treatment of eczema]. (2003) (2)
Occupational contact dermatitis from ninhydrin in a police officer (2010) (2)
Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology (2022) (2)
Present role of sublingual immunotherapy in allergic diseases (2007) (2)
Faculty Opinions recommendation of Systemic lupus erythematosus: a genetic epidemiology study of 695 patients from China. (2007) (2)
Nevoid Bag-Like Soft Fibromas (1999) (2)
Research needs in allergy (2012) (2)
[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]. (2020) (2)
[Molecular mechanisms of IgE regulation]. (1997) (2)
S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid (2022) (2)
Use of biologics in food allergy management (2021) (2)
In Memoriam / Announcements (1999) (1)
Current Standards and Improvements in the Use of SLIT Tablets for Allergen Immunotherapy (2017) (1)
Tolerance induction through non-avoidance to prevent persistent food allergy (TINA) in children and adults with peanut or tree nut allergy: rationale, study design and methods of a randomized controlled trial and observational cohort study (2022) (1)
Atopic dermatitis and food allergy: when and how to test? (2011) (1)
Allergic skin reactions (2008) (1)
Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis (2022) (1)
Genetic Associations and Differential mRNA Expression Levels of Host Genes Suggest a Viral Trigger for Endemic Pemphigus Foliaceus (2022) (1)
Elicitors of severe allergic reactions – reports from allergists and emergency doctors (2017) (1)
Guideline (S2k) on acute therapy and management of anaphylaxis - 2021 Update (2021) (1)
08. Musculoskeletal System & Rehabilitation (2018) (1)
2 Dose Optimizing Study of a Depigmented Polymerized Allergen Extract of Birch Pollen by Means of Conjunctival Provocation Test (2012) (1)
Drug anaphylaxis in children – data of the German-speaking anaphylaxis registry (2013) (1)
German S1 guideline: Contact dermatitis (2022) (1)
[Nutritional status of adult patients with atopic dermatitis]. (2002) (1)
Diversities of allergic pathologies and their modifiers: Report from the second DGAKI-JSA meeting. (2022) (1)
Mechanisms of IgE-Regulation (2006) (1)
[Current recommendations for the use of SCIT and SLIT]. (2006) (1)
Health-related quality of life and mental health in drug hypersensitivity reactions and drug-induced anaphylaxis: a systematic review and meta-analysis. (2023) (1)
Anaphylaxis: Revision of the Brighton collaboration case definition. (2022) (1)
A Tyrosine Adsorbed Modified Grass Allergen + MPL SCIT Demonstrates Clinically Improvement in Combined Symptom and Medication Score in Subjects with Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis (2022) (1)
Features and Predictors of Biphasic Anaphylaxis: Data from the European Anaphylaxis Registry (2020) (1)
Good tolerability when switching from an aqueous ultra‐rush Hymenoptera venom immunotherapy to a depot preparation (2020) (1)
POS0834 LONG-TERM OUTCOME OF SSC ASSOCIATED ILD: IMPROVED SURVIVAL IN PPI TREATED PATIENTS (2021) (1)
[Influence of nut and peanut allergy on the quality of life of adults]. (2022) (1)
Sublingual immunotherapy with grass pollen tablets demonstrated clinical efficacy in patients with rhinoconjunctivitis from the first pollen season, at peak season and throughout the season (2007) (1)
Isolation and phenotypic characterization of mucosal nasal lymphocytes by direct ex vivo analysis (2009) (1)
An interdisciplinary approach to characterize peanut‐allergic patients—First data from the FOOD@ consortium (2022) (1)
Patch testing shellac in consecutive patients—Data of the Information Network of Departments of Dermatology (IVDK) 2021 (2022) (1)
Leitlinie/Guidelines (2006) (1)
Current developments in the treatment of peanut allergy (2021) (1)
[Therapy of occupational skin diseases]. (2009) (1)
When and how to evaluate for immediate type food allergy in children with atopic dermatitis. (2021) (1)
Sublingual immunotherapy (2006) (1)
Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study (2022) (1)
Reply to Chirumbolo et al. (2018) (1)
Precision medicine reaching out to the patients in allergology – a German-Japanese workshop report (2021) (1)
Autoimmune thrombocytopenia in two patients with Sneddon’s Syndrome (2007) (1)
Allergic contact dermatitis in psoriasis (2019) (1)
Improvement In Quality Of Life With Administration Of A 300 IR Sublingual Tablet Of 5-grass Pollen Allergen Extract In Adults With Grass Pollen-induced Allergic Rhinoconjunctivitis (2012) (1)
5 Posttreatment, Long-Term Clinical Efficacy of a 300 IR Sublingual Tablet of 5-Grass Pollen Allergen Extract in Adults With Grass Pollen Induced Allergic Rhinoconjunctivitis (2012) (1)
Post-treatment, Long-term Clinical Efficacy Of A 300 IR Sublingual Tablet of 5-grass Pollen Allergen Extract In Adults With Grass Pollen-induced Allergic Rhinoconjunctivitis (2012) (1)
Perception of the coronavirus pandemic by patients with atopic dermatitis – Results from the TREATgermany registry (2021) (1)
[Comparative psychological aspects of itching and pain]. (2011) (1)
[IgG food allergies - a subject of controversy]. (2011) (1)
Allergological diagnostics of hypersensitivity reactions to drugs (2008) (1)
Etiologies of anaphylaxis (2014) (0)
219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid (2023) (0)
Use of biologics in allergic and type 2 inflammatory diseases in the current Covid 19 pandemic(a, b, c) (2020) (0)
[Food allergy: a diagnostic and therapeutic challenge]. (2022) (0)
Interferon T downregulates EGF-R expression on human melanoma cells—determination of the relevance of EGF and EGF-R on proliferation of human melanoma cells (1993) (0)
Long-term Safety Of A 300IR Sublingual Tablet Of 5-grass-pollen Allergen Extract In Adults With Grass-pollen-induced Allergic Rhinoconjunctivitis (2012) (0)
Itching and treatments in atopic dermatitis (AD): results from the German AD registry TREATgermany. (2022) (0)
Author response for "Food‐induced anaphylaxis morbidity: emergency department and hospitalizations data support preventive strategies" (2021) (0)
Lack of Harmonized Adherence Criteria in Allergen Immunotherapy Prevents Comparison of Dosing and Application Strategies: A Scoping Review. (2022) (0)
Biologics and immunotherapy Safety and efﬁcacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32 (2019) (0)
Subject Index Vol. 20, 2007 (2007) (0)
[Sublingual immunotherapy. Where are we now?]. (2011) (0)
157 The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults With Allergic Rhinitis (2012) (0)
541 1a,25-dihydroxyvitamin D3 inhibits CD40+IL-4-mediated IgE production by human B cells in vitro (2000) (0)
[Anaphylaxis - Causes, therapy and prevention]. (2017) (0)
Eczema herpeticatum recidivans (2007) (0)
Immunomodulation by Dietary n3-Polyunsaturated Fatty Acids (PUFA) In Vitro (2006) (0)
Allergy vaccination with peptides--SIT with major cat allergen Fel d 1 peptides: safety, tolerability and dose responses. (2009) (0)
Contents Vol. 208, 2004 (2004) (0)
Limited Reimbursement and Underuse of Digital Healthcare Concepts Are Major Barriers to Clinical Allergological Care in Germany. (2023) (0)
Management and outcome of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity. (2021) (0)
[Not Available]. (2016) (0)
Contents Vol. 71, 2005 (2005) (0)
Food-induced anaphylaxis: Data from the European Anaphylaxis Registry. (2023) (0)
Cow's milk and hen's egg anaphylaxis: A comprehensive data analysis from the European Anaphylaxis Registry (2023) (0)
Retinoic acid inhibits human B-cell IgE production in vitro by downregulation of epsilon germline transcription (1998) (0)
Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany. (2023) (0)
Subject Index Vol. 208, 2004 (2004) (0)
Practical patch testing in allergic contact dermatitis in children (2022) (0)
Effects of various synthetic retinoids on proliferation and melanogenesis towards human melanoma cells in vitro (1993) (0)
[Induction of penicillin tolerance during pregnancy : Allergological opinion on the recommendation of the current Guidelines on Diagnosis and Treatment of Syphilis (AWMF Registry No. 059-002)]. (2021) (0)
Acetylsalicylic acid potentiates passive systemic anaphylaxis in mice (2011) (0)
Associate Editor Andreas Radbruch (2013) (0)
Associate Editor Hirohisa Saito (2013) (0)
46 Operative Therapie (2014) (0)
Vegan diets from an allergy point of view – Position paper of the DGAKI working group on food allergy (2023) (0)
Diffusing capacity (DLCO) as a potential surrogate marker for scleroderma related lung disease–data from the german network for systemic sclerosis (2017) (0)
Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network (2019) (0)
Review article Insulin allergy: clinical manifestations and management strategies (2008) (0)
Contents Vol. 20, 2007 (2007) (0)
THU0339 PULMONARY INVOLVEMENT AND OUTCOME IN SYSTEMIC SCLEROSIS (SSC) – ILD-PH AS AN IMPORTANT SUBSET (2019) (0)
Autologous hematopoietic stem cell transplantation improves long-term survival—data from a national registry (2022) (0)
[Management of immunoglobulin-E-mediated food allergies : What remains and what is new?] (2022) (0)
Relations between perception and pain threshold levels in patients with atopic dermatitis (2004) (0)
Induction of penicillin tolerance during pregnancy: Allergological opinion on the recommendation of the current AWMF Guidelines on Diagnosis and Treatment of Syphilis (AWMF Registry No. 059-002) (2021) (0)
Explorer Research needs in allergy (2017) (0)
Faculty Opinions recommendation of Cyclosporine-A in severe chronic urticaria: the option for long-term therapy. (2011) (0)
More Than 3000 Patients Vasoactive Therapy in Systemic Sclerosis : Real-life Therapeutic Practice in Hunzelmann and The German Network for Systemic Scleroderma (2017) (0)
AB0181 Diffusing capacity and clinical characteristics of patients with systemic sclerosis – data from the german network for systemic sclerosis (2017) (0)
Author response for "9‐cis retinoic acid and 1.25‐dihydroxyvitamin D 3 drive differentiation into IgA + secreting plasmablasts in human naïve B cells" (2020) (0)
Vaccination against infectious agents and allergen-specific immunotherapy: A critical analysis (2023) (0)
32516 Efficacy of intravenous immunoglobulins (IVIG) in improving muscle and skin symptoms in dermatomyositis patients. Results of a large, randomized, placebo-controlled international phase III trial (ProDERM) (2022) (0)
Efficacy and safety of tralokinumab plus topical corticosteroids in patients with severe atopic dermatitis and prior history of dupilumab treatment: a post hoc subgroup analysis from ECZTRA 7 trial (2021) (0)
[Management of severe nut allergy in adults]. (2022) (0)
Health‐related quality of life in food and venom induced anaphylaxis and role of influencing factors (2022) (0)
N31 – Allergieprävention (S3) (2007) (0)
New compounds for the treatment of eczematous skin diseases (2002) (0)
Vitamin D3 (VD) and retinoic acid (RA) inhibit IgE production in vitro from normal and atopic donors (2002) (0)
Reply. (2020) (0)
Plenum 2: Anaphylaxie (2007) (0)
Advances in Food Additives (2016) (0)
IL-1α/β and IL-18 profiles and their impact on claudin-1, loricrin and filaggrin expression in patients with atopic dermatitis. (2023) (0)
Chemotherapy of metastatic malignant melanoma directed by in vitro sensitivity testing: 164 (1993) (0)
Dupilumab in moderate-to-severe atopic dermatitis: results from two randomized phase 3 trials (SOLO 1 & 2) (2017) (0)
The Janus kinase inhibitor 1 abrocitinib for the treatment of oral lichen planus. (2023) (0)
Immunmodulation durch Vitamin D (2011) (0)
906 CD40 mediated transcriptional activation of the human lymphotoxin gene depends on NF-kB activation (1996) (0)
Elicitors and cofactors of food-induced anaphylaxis (2013) (0)
Mechanismen der CD40/IL-4-abhängigen IgE-Regulation (2000) (0)
[Efficacy of tracrolimus 0.1% ointment in prurigo]. (2005) (0)
Obituary: Jörg Kleine-Tebbe. (2023) (0)
AB0169 Evaluation of frequency and type of physical therapy in more than 3400 patients with systemic sclerosis (2017) (0)
Response to “Targeted Use of Placebo Effects Decreases Experimental Itch in Atopic Dermatitis Patients: A Randomized Controlled Trial” (2021) (0)
Drug induced modulation of T cell activation and differentiation in atopic dermatitis patients (2009) (0)
Correction required. (2010) (0)
Different phenotypes of drug-induced anaphylaxis-Data from the European Anaphylaxis Registry. (2022) (0)
MALT (»mucosa-associated lymphoid tissue«) (2016) (0)
Faculty Opinions recommendation of Health-related quality of life in systemic sclerosis: a systematic review. (2009) (0)
Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab (2022) (0)
Explorer 2015 update of the evidence base (2015) (0)
FRI0488 Analysis of REAL Life Vasoactive Therapy in over 3000 Patients with Systemic Sclerosis (SSC) Reveals Considerable Undertreatment and Significant Changes of Treatment Practice since 2004 (2014) (0)
AB0584 DOES ANTI-ACID TREATMENT INFLUENCE DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS INTERSTITIAL LUNG DISEASE (SSC-ILD)? DATA FROM THE GERMAN SSC-NETWORK (2020) (0)
Invitation to a Survey on the actual Effects of the COVID-19 Pandemic on AIT (2020) (0)
Subject Index Vol. 71, 2005 (2005) (0)
Associate Editor Carsten B. Schmidt-Weber (2013) (0)
Iconographies supplémentaires de l'article : Data from the anaphylaxis registry of the German-speaking countries (2015) (0)
Supplementary Material for: The Impact on Allergy-Related Cells of a Birch Pollen Allergoid, with and without Monophosphoryl Lipid A, in Comparison with the Native Equivalent (2017) (0)
Associate Editor Thomas Schwarz (2013) (0)
Implementation of anaphylaxis management guidelines (2012) (0)
Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review (2017) (0)
Faculty Opinions recommendation of Diagnostic utility of anti-Ro52 detection in systemic autoimmunity. (2010) (0)
AB0215 A LATE ONSET OF SYSTEMIC SCLEROSIS IS ASSOCIATED WITH A MORE RAPIDLY PROGRESSING CLINICAL PHENOTYPE IN LCSSC PATIENTS (2019) (0)
Sublinguale Immuntherapie (2006) (0)
Food anaphylaxis and augmentation factors – data of the German-speaking anaphylaxis registry (2011) (0)
Developing integrated care pathways for atopic dermatitis—Challenges and unmet needs (2023) (0)
CHAPTER 58 – Non-Bullous Skin Diseases: Alopecia, Vitiligo Psoriasis, and Urticaria (2006) (0)
Prevalence of sensitization to molecular food allergens in Europe: A systematic review (2022) (0)
Immune cell profiling reveals natural killer and T cell subpopulations to be associated with atopic dermatitis severity (2022) (0)
Paediatric anaphylaxis in South Africa (2022) (0)
Commentary on ''dynamic analysis of histamine-mediated attenuation of acetylcholine-induced sweating via GSK3β activation''. (2014) (0)
In reply. (2015) (0)
Topic Immunmodulators for the Treatment of Eczematous Skin Diseases (2003) (0)
Post-treatment Efficacy Of House Dust Mites (HDM) Sublingual Immunotherapy (SLIT) Tablets In Adult Patients (2011) (0)
document of the European of and and the Academy of (0)
Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis. (2023) (0)
Intake of cardiovascular drugs promote severity of anaphylaxis (2015) (0)
[Editorial of the special issue on food allergies and other food intolerances]. (2016) (0)
New data on scleroderma renal crisis and predictive factors from more than 3000 patients (2015) (0)
Associate Editor Martin Röllinghoff (2013) (0)
S139 Evaluation of the postsurgical pain management after urological surgery (2009) (0)
UP-3.095: Evaluation of the Postsurgical Pain Management after Urological Surgery (2009) (0)
International consensus on (ICON) anaphylaxis The Harvard has made this article openly available. Please share how this access benefits you. Your story matters (2014) (0)
[World Allergy Organization Anaphylaxis Guidance 2020]. (2021) (0)
Rituximab for treatment refractory ocular cicatricial pemphigoid (OCP) (2014) (0)
AB0765 Development and assessment of a structured training program for patients with systemic sclerosis (2018) (0)
Abstracts, 12th Symposium of the Working Group on Insect Venom Allergy, German Society of Allergy and Clinical Immunology (DGAKI), Frankfurt, Germany, November 20/21, 2020 (2020) (0)
F.55. Extensive TNF-Alpha Expression in Cutaneous Lesions from Patients with Lupus Erythematosus (2006) (0)
Basophil Activation In Food Allergic Patients (2007) (0)
Training Approach to Anaphylaxis (2011) (0)
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis (2023) (0)
Correction. (2020) (0)
New compounds for the treatment of eczematous skin diseases (2002) (0)
Dose-response relationship of a new Timothy grass pollen allergoid in comparison to a 6-grass pollen allergoid Condensed title for a running head : Dose-response relationship of a Timothy grass pollen allergoid (2017) (0)
COVID-19 Vaccination of Allergic Patients in Conjunction with allergen immunotherapy (AIT) – A position paper of the Association of German Allergists (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI) (2021) (0)
Real‐world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry (2022) (0)
Edinburgh Research Explorer In-flight allergic emergencies (2018) (0)
Stringent elimination diet. (2009) (0)
New insights into mast cell and B-lymphocyte function in allergy and inflammation (2000) (0)
Canadian Anaphylaxis Network-Predicting Recurrence after Emergency Presentation for Allergic REaction (CAN-PREPARE): a prospective, cohort study protocol (2022) (0)
Influence of bosentan on fingertip rewarming in patients with systemic sclerosis (2013) (0)
An update on anaphylaxis and urticaria. (2022) (0)
Selection of the optimal dose for an ultra-short course subcutaneous immunotherapy (SCIT) for Rhinoconjunctivitis for Birch Allergic patients (2017) (0)
[Editorial of the special issue Food allergy and other food intolerances : part 2]. (2016) (0)
17in atopic dermatitis (2007) (0)
Double blind placebo-controlled allergen-specific immunotherapy with the hypoallergenic folded variant of rBet v 1-FV in birch associated soy allergy (2016) (0)
SSC-OVERLAP SYNDROMES: A DISTINCT CLINICAL SUBGROUP WITH SIGNIFICANT DIFFERENCES IN DISEASE PROGRESSION COMPARED TO LSSC AND DSSC PATIENTS. (2014) (0)
[Placebo response - Mechanisms and clinical applications]. (2016) (0)
COVID-19-vaccination in patients receiving allergen immunotherapy (AIT) or biologics - EAACI recommendations (2021) (0)
8 Sexually transmitted diseases (2014) (0)
Activation Of Allergen-specific T Cells In Vivo During Specific Immunotherapy With Depigoid Allergen Extracts (2007) (0)
CALORIC INTAKE, NOT CARBOHYDRATE OR FAT CONSUMPTION, DETERMINES WEIGHT LOSS (2003) (0)
Statements about COVID-19/ Statements zu COVID-19 (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Margitta Worm?

Margitta Worm is affiliated with the following schools:

Humboldt University of Berlin
University of California, Irvine

Margitta Worm's Academic­Influence.com Rankings

Why Is Margitta Worm Influential?

Margitta Worm's Published Works

Published Works

What Schools Are Affiliated With Margitta Worm?

Margitta Worm's AcademicInfluence.com Rankings